Delivery Order SPE2DB22D2006-SPE2DB23FV9GR
- Not listed
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, which is a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., both of which are for-profit organizations. The contract has a ceiling value of $15,378.69 and a period of performance ending on April 25, 2023. This is a delivery order contract with a firm fixed price pricing type. The...
- The federal contract award is for the delivery of Ondansetron ODT 4 mg tablets in 30-count packages to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 11, 2025, with a ceiling value of $3,739.59 and a completion date of June 12, 2025. The contract is a firm fixed-price delivery order, and it is not set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $26,644.25 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $2,354.88 and is a firm fixed-price delivery order contract that runs through April 28, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds...
- The federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,597.96 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order contract with a firm fixed price pricing type, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablet supplies to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor for this $18,477.96 Firm Fixed Price Delivery Order is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract has an ultimate completion date of October 24, 2023 and was awarded on October 23, 2023. The contract is not designated with any set-aside...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for a ceiling value of $2,271.95. The contract is a delivery order with a firm fixed-price pricing type and a completion date of January 30, 2024. The award was not set aside for any special designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor that provides a wide range of medical supplies and medications to various government agencies. The contract has a ceiling value of $3,764.69 and is a firm-fixed-price delivery order with an ultimate...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets in quantities of 30. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $8,939.93 and an ultimate completion date of May 11, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements, indicating open...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 6, 2025, with a ceiling value of $2,586.96 and a completion date of February 7, 2025. The contract is a delivery order with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds an...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB23FV9GRDelivery Order
This federal contract award is for the delivery of ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company that is a subsidiary of the parent company Cencora, Inc. The total ceiling value of the contract is $1,327.99, with a period of performance through April 25, 2023. This is a Firm Fixed Price Delivery Order contract, without any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/24/23 |